1-14 of 14
gefitinib
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Activated Leukocyte Cell Adhesion Molecule (ALCAM) Regulate Myeloma Cancer Stem Cell Mediated Myelomagenesis and Chemoresistance

Yuhuan Zheng, Hongmei Luo, Dan Zhang, Fangfang Wang
Journal: Blood
Blood (2018) 132 (Supplement 1): 3190.
https://doi.org/10.1182/blood-2018-99-111740
Published: 2018
Journal Articles

Development of a Clinically Relevant in Vitro Drug Screening Platform for Chemo-Refractory AML Patients

Stephen Sze Yuen Lam, Chae Yin Cher, Nelson Ka Lam Ng, Eric SK Ho, Cheuk Him Man, PhD, Howard CH Chow, Connie J Eaves, Alice MS Cheung, PhD, Anskar Y.H. Leung, MD
Journal: Blood
Blood (2014) 124 (21): 3624.
https://doi.org/10.1182/blood.V124.21.3624.3624
Published: 2014
Journal Articles

Aberrant Activation of Epidermal Growth Factor Receptor in MPN May Respond to the Kinase Inhibitor Gefitinib

Debora A Casolari, PhD, Diana G Iarossi, BSc (Hons), Carolyn M Butcher, MMedSc(Hons), Sarah C Bray, PhD, Wendy T Parker, PhD, Chris N Hahn, PhD, Susan Branford, PhD, Peter Bardy, MD, Ian D Lewis, MBBS, PhD, Hamish S Scott, PhD, Steven W Lane, MD PhD, David M Ross, MBBS, PhD FRACP, FRCPA, Richard J D'Andrea, PhD
Journal: Blood
Blood (2014) 124 (21): 1882.
https://doi.org/10.1182/blood.V124.21.1882.1882
Published: 2014
Journal Articles

Protein Degradation and Resultant Hsp90 Dephosphorylation as An Alternative C-KIT Kinase Inhibition Strategy

Bo Zhang, Haitong Fang, Xiaofen Pan, Jun Xie, Yonglong Chen, Sai-Juan Chen, Guangbiao Zhou, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4361.
https://doi.org/10.1182/blood.V116.21.4361.4361
Published: 2010
Journal Articles

Establishment of a Novel Canine Mastocytoma Cell Line, NI-1: a Model for Studying Resistance Against KIT Tyrosine Kinase Inhibitors In Canine Neoplastic Mast Cells

Emir Hadzijusufovic, Barbara Peter, Harald Herrmann, Karina Schuch, Tuddow Thaiwong, Vilma Yuzbasiyan-Gurkan, Thomas Rülicke, Winfried Pickl, Michael Willmann, Peter Valent, M.D.
Journal: Blood
Blood (2010) 116 (21): 4936.
https://doi.org/10.1182/blood.V116.21.4936.4936
Published: 2010
Journal Articles

A Novel Anilinoquinazoline Derivative Inhibits Growth of High-Risk Myeloma Cells In Vivo and Regulates Differentiation of Osteoclasts

Yoshie Ozaki, Yuhei Naito, Hiroshi Yanagawa, PhD, Yuya Suzuki, Wenlin Du, MD, PhD, Taketo Yamada, MD, PhD, Koichi Matsuo, MD, PhD, Nobuhide Doi, PhD, Shiro Iijima, PhD, Maiko Matsushita, MD, PhD, Kayoko Tahara, PhD, Yutaka Hattori, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4076.
https://doi.org/10.1182/blood.V116.21.4076.4076
Published: 2010
Journal Articles

Increased Proliferation Induced by Constitutive Activation of the Src-Kinase Lyn and Aberrant mTOR Signaling in AML Is Abrogated by the EGFR-Inhibitor Erlotinib.

Simone Boehrer, MD, PhD, Lorenzo Galluzzi, phD, Lionel Ades, MD, Celine Fouassier, Claude Gardin, MD, Pierre Fenaux, MD, PhD, Guido Kroemer, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3813.
https://doi.org/10.1182/blood.V114.22.3813.3813
Published: 2009
Journal Articles

Syk Is a New Target for AML Differentiation.

Cynthia K. Hahn, BA, Kenneth N. Ross, PhD, Rose M. Kakoza, BA, Steven A. Carr, PhD, Jinyan Du, PhD, Shao-En Ong, PhD, Todd R. Golub, MD, Kimberly Stegmaier, MD
Journal: Blood
Blood (2007) 110 (11): 209.
https://doi.org/10.1182/blood.V110.11.209.209
Published: 2007
Journal Articles

Activity of Tyrosine Kinase Inhibitors in Multiple Myeloma.

Reinhold Munker, MD, Cory Cordova, BS, Paula Polk, BS, Charles V. Wendling, MD, Amanda W. Sun, MD PhD, James A. Cardelli, PhD
Journal: Blood
Blood (2007) 110 (11): 4804.
https://doi.org/10.1182/blood.V110.11.4804.4804
Published: 2007
Journal Articles

2006 RADAR Report Card on Conversion Rates from Accelerated FDA Approval to Regular FDA Approval for Drugs Used To Treat Hematologic Malignancies: Policy Changes Continue To Be Needed.

Andrew J. Lurie, BGS, Mark V. Mai, Martin S. Tallman, MD, June McCoy, MD JD MPH, Charles L. Bennett, MD PhD MPP
Journal: Blood
Blood (2006) 108 (11): 3318.
https://doi.org/10.1182/blood.V108.11.3318.3318
Published: 2006
Journal Articles

Thalidomide-Associated Thromboembolism in Cancer: Reimbursement for Thalidomide’s “Off-Label” Prescribing under the 2004 Medicare Oral Pharmaceutical Demonstration Project Raises Concerns.

Andrew M. Evens, DO, MS, June M. McKoy, MD, MPH, JD, Paul R. Yarnold, PhD, Kathyrn McCaffrey, BA, Charles L. Bennett, MD, PhD, MPP
Journal: Blood
Blood (2005) 106 (11): 2244.
https://doi.org/10.1182/blood.V106.11.2244.2244
Published: 2005
Journal Articles

Gefitinib adopts orphan kinases in leukemia

Animesh Pardanani, Ayalew Tefferi
Journal: Blood
Blood (2005) 106 (8): 2600–2601.
https://doi.org/10.1182/blood-2005-07-3008
Published: 2005
Journal Articles

Gefitinib induces myeloid differentiation of acute myeloid leukemia

Kimberly Stegmaier, Steven M. Corsello, Kenneth N. Ross, Jenny S. Wong, Daniel J. DeAngelo, Todd R. Golub
Journal: Blood
Blood (2005) 106 (8): 2841–2848.
https://doi.org/10.1182/blood-2005-02-0488
Published: 2005
Includes: Supplemental data
Journal Articles

Amphiregulin Is Produced by Myeloma Cells and Is Involved in Tumor-Environment Interactions in Multiple Myeloma.

Karène Mahtouk, Dirk Hose, Thierry Reme, John De Vos, Michel Jourdan, Jérome Moreaux, Geneviève Fiol, Marc Raab, Eric Jourdan, Marion Moos, Hartmut Goldschmidt, Jean-François Rossi, Friedrich W. Cremer, Bernard Klein
Journal: Blood
Blood (2004) 104 (11): 4306.
https://doi.org/10.1182/blood.V104.11.4306.4306
Published: 2004